The repository for NTD operational research studies

The study will take place in the context of a larger clinical trial (FIRM-UP) that includes 4000 women affected by schistosomiasis. For the current study, the team will develop the following “work packages” to better understand community awareness of FGS, clinical diagnosis, and how to provide enhanced training:

• Work Package 1: design and implement a community-based awareness campaign, using community surveys, focus group discussions, and in-depth interviews, to determine uptake and acceptability of FGS services. This will be followed with an end-line survey to assess change in the indicators following the campaign.
• Work Package 2: establish a diagnostic package with digital colposcopy (using smartphones to capture images) and on-site microscopy.
• Work Package 3: provide a refresher training for FIRM-UP study workers, organize a colposcopy and digital imaging workshop, and extended training for staff coming from other endemic regions in Madagascar. An open-source learning platform (‘Moodle’) will be developed to exchange training and learning materials.

This study aims to integrate screening and preventive treatment with praziquantel for FGS into routine HIV and reproductive health care visits for women. A pilot study will be conducted in four health facilities with a target sample size of 4800 women over a six-month period. Trainings will be conducted for health workers and the team will use a participatory design process with key stakeholders to ensure that barriers to integration in the health system and community participation are addressed. A scale-up report will be written with stakeholder engagement and all training materials that were developed will be instantly available for use in other clinics in Cote d’Ivoire. Delivery of praziquantel to the four facilities in the pilot study will utilize existing drug-procurement and delivery systems to ensure sustainability.

This proof of concept study will take place over a 10-month period. They aim to compare the feasibility and acceptability of mobile gynecological clinics versus traditional, static health posts. The primary research question, Where urogenital schistosomiasis is endemic, can a static health outpost versus a mobile clinic deliver better diagnosis and treatmnet of FGS, HIV, HPV, and cervical cancer in an acceptable and cost-effective manner to women (14-30 years), will be answered through the following activities:

1. Development of a consortium on FGS bringing together high-profile researchers, policy makers, program implementers, and health professionals
2. Training of health professionals (nurses, physicians, community health workers) with follow up sessions to raise awareness and diagnostic capabilities through colposcopic imagery. Health workers in remote areas will utilize telehealth to transmit images for quality checks by a specialist. The team will measure the % correlation between field results and telemedicine results to determine feasibility.
3. Precision mapping in select districts to determine areas with the highest schistosomiasis prevalence through parasitological surveys
4. Pilot test mobile service delivery for FGS, HIV, HPV, and other common gynecological issues in two of the four districts. This will include a cost analysis to make a business case for scalability.

Primary Objective: To evaluate and develop MMDP services in Nigeria to be responsive to patient and provider perspectives using community based participatory research approaches in a participatory action research cycle

Formative research question: To what extent are the support needs of people affected by NTDs being met?

Intervention research question: How can new programme strategies be adapted to meet outstanding need?

1. What are the community health system barriers that affect the manner in which morbidity management and disability prevention services can be made accessible to hydrocele patients from migrant and mobile fishing populations?
2. What processes and actors at community level are crucial for the integration of morbidity management and disability prevention services so as to make them accessible to hydrocele patients from migrant and mobile fishing populations?
3. What community health system strategies can be used to increase the uptake of morbidity management and disability prevention services among hydrocele patients from migrant and mobile fishing populations?
 

1. What are the supply-side health systems enablers and constraints to equitable delivery of NTD program interventions for Onchocerciasis & LF in hard-to-reach rural areas?

2. Which demand-side (socioeconomic and disability status) factors hinder equitable access to NTD program interventions for Onchocerciasis & LF in hard-to-reach rural areas?

3. What is the prevalence of disability among health facility attendees vs. persons affected by NTDs within the community in hard-to-reach rural areas?

4. What factors hinder disability-inclusion for NTD program interventions for Onchocerciasis & LF in hard-to-reach rural areas?